title: [Influence of erythropoietin therapy on systolic function of myocardium in patients with cardiorenal syndrome on hemodialysis].
abstract: We observed 93 patients with CRS 2,4,5 types having anemia, systolic dysfunction of left ventricle (LV) - EF ≤45% and heart failure functional class (FC) II-IV (NYHA).  All patients are under HD and were treated with EPO 3 times per week in a period of 6 months. We revealed improvement of LV EF 4,3 % and HF FC after EPO treatment and concluded that EPO therapy causes regression of LV hypertrophy, improves LV function and quality of life.
authors: Yerevan State Medical University after M. Heratsi, Yerevan, Armenia.
authors: A
authors: A
authors: Minasyan
mesh_terms: D000740:Anemia / Q000188:drug therapy; D059347:Cardio-Renal Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy*; D011788:Quality of Life; D006435:Renal Dialysis; D016896:Treatment Outcome; D016277:Ventricular Function, Left / Q000187:drug effects
chemical_list: D004921:Erythropoietin